The meeting will focus on recent advances in hypertension research and foster connections among experts in hypertension and its relationship to cardiac and kidney disease, stroke, obesity and genetics. AHA’s Hypertension Scientific Sessions is a collaborative effort between AHA’s Council on Hypertension and Council on the Kidney in Cardiovascular Disease.
Dr Jorg Taubel will be in attendance. Please reach out if you would like to meet with Dr Taubel at the event via our contact page.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
